News
C3.ai (AI) shares rose 2.9% in late morning trading on Monday after the company announced it had signed a deal with Brazil's Eletrobras. Read for more.
Gold Fields has performed well, up 34.77% since my Buy call, but current valuations now look stretched versus peers and ...
South Korea's Posco formed a 50-50 joint venture partnership with JW Steel to build an integrated steel mill in India with an ...
Dayforce stock nears acquisition premium with limited upside due to slower growth and competition. Click here to find out why ...
Nvidia (NVDA) was in focus on Monday as investment firm Cantor Fitzgerald upped its price target. Read for more.
Gemini plans up to a $400M IPO for debt and growth amid declining revenue, rising costs, and crypto market challenges. Click ...
Is the good news fully priced in? Explore key insights on demand, stockpiling, and margins. Read why NVDA is a Hold.
HF Foods faces margin pressure from tariffs and weak traffic, with limited upside despite stable cash flow and record Q2 ...
AT&T's earnings are finally aligning with its streamlined business after years of divestitures. Click here to find out why T ...
Crescent Biopharma is an early-stage biotech with a promising PD-1/VEGF bispecific antibody. Read why I rate CBIO stock as a ...
With a market capitalization larger than entire countries’ equity markets, the S&P 400® highlights the global relevance of ...
Tonix Pharmaceuticals ( NASDAQ: TNXP) is off ~20% in Monday trading despite winning U.S. FDA approval of its fibromyalgia treatment Tonmya (cyclobenzaprine sublingual tablets) on Friday.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results